TJ-102

N/A

Report date: 2025/07/08 10:29:30

Base Information

Drug NameTJ-102
Drug Alias NameTJ-102
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > PY-4CAR2 payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > PE-E2K payload +[5] 
Mechanisms of ActionDNA topoisomerase I inhibitorsMicrotubule inhibitorsAnti-Cadherin-6 +[4] 
TargetsDNA topoisomerase ICadherin-6Folate receptor alpha
Therapy Area/IndicationsOvarian NeoplasmsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPhrontline Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPhrontline Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A